Metabolic syndrome that affects almost 34% of American adults is characterized by reduced HDL cholesterol, increased triglycerides and leads to fasting plasma glucose and blood pressure. The studies have shown that fructose found in high-fructose corn syrup and table sugar is a major cause of these problems. Stevia First Corp (OTCMKTS:STVF) aims to combat the increasing problems by replacing sugar via increased global supply of company’s compelling zero-calorie alternative.
The product
Stevia First product, also named as Stevia is a zero-calorie natural sweetener. It possesses all the health benefits of cutting off calories, together with an impressive track record of safety. The product has negligent impact on insulin and various other metabolic markers than HFCS or sugar, and therefore contributes less to metabolic syndrome.
The reputation
Stevia recorded great success within the food and beverage industry, such as Coca-Cola’s Vitaminwater Zero. It is privately owned by the company through its Energy Brands subsidiary. In the very first year, the product ‘Vitaminwater Zero’ generated over $100 million in revenue, according to Statista.com. Due to this success with Stevia products, various multinational firms are seeking to find measures to increase global supply of Stevia.
The developments
Due to the growing demand, Stevia First Corp (OTCMKTS:STVF) has formulated a proprietary agri-bio method that considerably reduces the labor-intensive procedure of leaf production. The Company has achieved this because of the development of unique bio processing measures that could increase annual production of stevia leaf per acre.
The company possesses intellectual property associated to these production measures and also have additional technologies developed to modernize its stevia supply chain. In last August, the company also finalized a technology license and distribution deal with Qualipride to soon become the sole North American stevia producer.
In last trading session, the stock price of STVF surged more than 13% to close the trading session at $0.250. The gains came at a share volume of 417,539 compared to average share volume of 182,527.
